Product
Advertisement
SARS-CoV-2 Omicron Detection Antibodies
The Omicron (B.1.1.529) strain is by far the most divergent SARS-CoV-2 variant. It is critical to re-evaluate the effectiveness of the current diagnostics and therapeutics against this new variant. Sino Biological has developed recombinant Omicron Spike and Nucleocapsid proteins and validated all available antibodies against the Omicron proteins.
- Antibody Pairs for the Detection of Omicron Nucleocapsid
Sino Biological has identified seven top pairs of antibodies for the detection of Omicron nucleocapsid protein. - Antibodies for the Detection of Omicron Spike
Sino Biological has screened a panel of previously established spike antibodies for their ability to detect the Omicron nucleocapsid protein.
About Sino Biological
Sino Biological is an international reagent supplier and service provider. The company specializes in recombinant protein production and antibody development. All of Sino Biological's products are independently developed and produced, including recombinant proteins, antibodies and cDNA clones. Sino Biological is the researchers' one-stop technical services shop for the advanced technology platforms they need to make advancements. In addition, Sino Biological offers pharmaceutical companies and biotechnology firms pre-clinical production technology services for hundreds of monoclonal antibody drug candidates
